Cita APA (7a ed.)

Hamilton, D. O., Main-Ian, A., Tebbutt, J., Thrasher, M., Waite, A., & Welters, I. (2021). Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19. BMC.

Cita Chicago Style (17a ed.)

Hamilton, David Oliver, Alexander Main-Ian, Jessie Tebbutt, Maya Thrasher, Alicia Waite, y Ingeborg Welters. Standard- Versus Intermediate-dose Enoxaparin for Anti-factor Xa Guided Thromboprophylaxis in Critically Ill Patients with COVID-19. BMC, 2021.

Cita MLA (8a ed.)

Hamilton, David Oliver, et al. Standard- Versus Intermediate-dose Enoxaparin for Anti-factor Xa Guided Thromboprophylaxis in Critically Ill Patients with COVID-19. BMC, 2021.